The relationship of these miRNAs to Hb and the number of erythrocytes and the hematocrit is interesting since both animal and human studies have shown that plasma Hb level impacts the clinical outcome of MI, and anemia is a risk factor in post-MI evolution [29,30,31,32,33,34]. Here, GSTM1 is linked to anemia.